Description
Interpreting the flexibilities under the TRIPS agreement.- Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review.- Compulsory license and government use.- Access to genome editing technologies.
Reviews
There are no reviews yet.